BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29153094)

  • 1. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.
    Tooze JA; Hamzic E; Willis F; Pettengell R
    Cancer Genet; 2017 Dec; 218-219():20-38. PubMed ID: 29153094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Wu J; Zhang Y; Sun L; Zhai Q
    Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
    Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.
    Parry HM; Stevens T; Oldreive C; Zadran B; McSkeane T; Rudzki Z; Paneesha S; Chadwick C; Stankovic T; Pratt G; Zuo J; Moss P
    Oncotarget; 2016 Oct; 7(42):68513-68526. PubMed ID: 27655680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Pei J; Robu V; Feder M; Cheung M; Neumann-Domer E; Talarchek J; Dulaimi E; Millenson MM; Testa JR
    Cancer Genet; 2014 Mar; 207(3):98-102. PubMed ID: 24704113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.
    Strati P; Parikh SA; Chaffee KG; Achenbach SJ; Slager SL; Call TG; Ding W; Jelinek DF; Hanson CA; Kay NE; Shanafelt TD
    Br J Haematol; 2017 Jul; 178(1):99-105. PubMed ID: 28386906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
    Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
    HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
    Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
    Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?
    Santos FP; O'Brien S
    Cancer J; 2012; 18(5):396-403. PubMed ID: 23006943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.
    Díez P; Lorenzo S; Dégano RM; Ibarrola N; González-González M; Nieto W; Almeida J; González M; Orfao A; Fuentes M
    Proteomics; 2016 Apr; 16(8):1193-203. PubMed ID: 26910488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
    Jones D; Benjamin RJ; Shahsafaei A; Dorfman DM
    Blood; 2000 Jan; 95(2):627-32. PubMed ID: 10627472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.
    Szurián K; Csala I; Piurkó V; Deák L; Matolcsy A; Reiniger L
    Leuk Res; 2017 Jul; 58():39-42. PubMed ID: 28407516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
    Kriston C; Plander M; Márk Á; Sebestyén A; Bugyik E; Matolcsy A; Barna G
    Ann Hematol; 2018 Nov; 97(11):2145-2152. PubMed ID: 29955944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
    Martínez-Trillos A; Pinyol M; Delgado J; Aymerich M; Rozman M; Baumann T; González-Díaz M; Hernández JM; Alcoceba M; Muntañola A; Terol MJ; Navarro B; Giné E; Jares P; Beà S; Navarro A; Colomer D; Nadeu F; Colado E; Payer AR; García-Cerecedo T; Puente XS; López-Otin C; Campo E; López-Guillermo A; Villamor N
    Leuk Lymphoma; 2018 Oct; 59(10):2318-2326. PubMed ID: 29115891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low number of DNA copy number changes in small lymphocytic lymphoma.
    Autio K; Aalto Y; Franssila K; Elonen E; Joensuu H; Knuutila S
    Haematologica; 1998 Aug; 83(8):690-2. PubMed ID: 9793251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
    Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
    Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
    Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.